Previous 10 | Next 10 |
home / stock / mrvl / mrvl articles
U.S. stocks are likely to remain weak on Thursday, major index futures indicated, as lower bond yields stayed elevated and mixed earnings dampened ...
The upcoming quarterly results of NVIDIA Corp (NASDAQ:NVDA) are not just a matter of interest for the company, but also for six other AI-related st...
Bitdeer Technologies Group (NASDAQ: BTDR) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This comp...
Two technology sector AI plays — Arista Networks Inc (NYSE:ANET) and Globalfoundries Inc (NASDAQ:GFS) — will be reporting their first-quarter e...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 20 years by 1.99% on an annualized basis producing an average annual return of...
Microsoft Corp (NASDAQ:MSFT), Meta Platforms Inc (NASDAQ:META), and Google parent Alphabet Inc (NASDAQ:GOOG) (NA...
The Nasdaq 100 closed higher by around 1% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it co...
Evercore ISI Group analyst Mark Lipacis initiated coverage on Marvell Technology Inc (NASDAQ:MRVL) with an Outperform rating and a&n...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 15 years by 1.17% on an annualized basis producing an average annual return of...
News, Short Squeeze, Breakout and More Instantly...
Marvell Technology Inc. Company Name:
MRVL Stock Symbol:
NASDAQ Market:
Marvell Technology Inc. Website:
Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has ...
2024-07-15 18:00:00 ET Broadcom (NASDAQ: AVGO) and Marvell Technology (NASDAQ: MRVL) usually don't attract as much attention as higher-growth chipmakers like Nvidia (NASDAQ: NVDA) . But like Nvidia, both diversified chip specialists are benefiting from the rapid ...
Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbate...